Clinical Trial Update: A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

View source ↗

Summary

The record notes the completion of a clinical trial in adults with major depressive disorder and anhedonia who had an inadequate response to current antidepress…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Status: COMPLETED